乐心医疗 (300562.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	996.6M	986.2M	984.0M	884.3M	1.1B
Cost of Revenue	640.5M	635.1M	638.9M	610.7M	812.7M
Gross Profit	356.1M	351.1M	345.1M	273.6M	252.4M
Operating Expenses
R&D Expense	95.4M	95.1M	96.8M	108.3M	136.9M
SG&A Expense	—	—	—	—	—
General & Admin Expense	70.0M	69.6M	88.4M	72.7M	66.3M
Selling & Marketing Expense	68.2M	77.0M	93.8M	71.7M	67.1M
Other Expenses	—	—	—	—	—
Total Operating Expenses	250.3M	251.8M	269.3M	250.6M	247.0M
Cost and Expenses	890.8M	886.9M	908.2M	861.3M	1.1B
Operating Income (EBIT)	95.1M	86.3M	58.4M	34.5M	(41.1M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	93.2M	84.3M	60.0M	33.1M	(44.6M)
Income Tax Expense	3.8M	4.1M	1.9M	1.9M	(6.4M)
Bottom Line
Net Income	91.1M	82.0M	61.4M	34.4M	(32.4M)
Earnings from Cont. Ops	89.4M	80.3M	58.2M	31.2M	(38.2M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	91.1M	82.0M	61.4M	34.4M	(32.4M)
Per Share
Basic EPS	CN¥0.42	CN¥0.38	CN¥0.28	CN¥0.16	(CN¥0.15)
Diluted EPS	CN¥0.42	CN¥0.38	CN¥0.28	CN¥0.16	(CN¥0.15)
Revenue Per Share	CN¥4.56	CN¥4.53	CN¥4.53	CN¥4.11	CN¥4.94
Shares
Basic Shares Outstanding	218.3M	217.5M	217.1M	215.2M	215.7M
Diluted Shares Outstanding	218.3M	217.5M	217.1M	215.2M	215.7M
Profitability Metrics
EBITDA	—	112.1M	83.9M	62.4M	(13.1M)
D&A	—	25.7M	25.5M	27.9M	28.0M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026